Published: 23 November 2020
Author(s): Peter W. Horby, Jonathan R. Emberson
Issue: January 2021
Section: Commentary

The place of hydroxychloroquine in the prevention and treatment of COVID-19 has been controversial, with contrasting claims and high-emotions. It was initially proposed as treatment or prophylaxis for COVID-19 based upon data reporting that chloroquine and hydroxychloroquine inhibited SARS-CoV-2 virus replication in cell culture systems. Interest accelerated rapidly as early reports from observational studies of clinical efficacy in COVID-19 patients emerged and hydroxychloroquine soon began to appear in clinical treatment guidelines.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.